Understanding Comorbidities of Respiratory Models as Novel Platforms for Drug Discovery.
- DOI
- 10.1021/acsptsci.4c00484
- Published
- 2024-10-25
- Container
- ACS Pharmacol Transl Sci
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acsptsci.4c00484,
title = {Understanding Comorbidities of Respiratory Models as Novel Platforms for Drug Discovery.},
author = {De Luca SN and Gunatilaka A and Coward-Smith M and Gomez HM and Kim RY and Stenekes A and Chan SMH and Wang W and Tan D and Vlahos R and Stewart AG and Donovan C.},
year = {2024},
journal = {ACS Pharmacol Transl Sci},
doi = {10.1021/acsptsci.4c00484},
url = {https://doi.org/10.1021/acsptsci.4c00484}
}RIS
TY - JOUR TI - Understanding Comorbidities of Respiratory Models as Novel Platforms for Drug Discovery. AU - De Luca SN AU - Gunatilaka A AU - Coward-Smith M AU - Gomez HM AU - Kim RY AU - Stenekes A AU - Chan SMH AU - Wang W AU - Tan D AU - Vlahos R AU - Stewart AG AU - Donovan C. PY - 2024 JO - ACS Pharmacol Transl Sci DO - 10.1021/acsptsci.4c00484 UR - https://doi.org/10.1021/acsptsci.4c00484 ER -
APA
SN, D. L., A, G., M, C., HM, G., RY, K., A, S., SMH, C., W, W., D, T., R, V., AG, S., & C., D. (2024). Understanding Comorbidities of Respiratory Models as Novel Platforms for Drug Discovery.. ACS Pharmacol Transl Sci. https://doi.org/10.1021/acsptsci.4c00484
Source records
- europe-pmc · retrieved 2026-09-27T15:41:42.390Z